Sertraline treatment for alcohol dependence: Interactive effects of medication and alcoholic subtype

Alcoholism: Clinical and Experimental Research

Volumn 24, Issue 7, 2000, Pages 1041-1049

  Pettinati, Helen M ^a,b   Volpicelli, Joseph R ^a,b   Kranzler, Henry R ^c   Luck, Gary ^a,b   Rukstalis, Margaret R ^a,b   Cnaan, Avital ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Alcoholic Subtypes; Alcoholism; Sertraline; SSRI Pharmacotherapy

Indexed keywords

ALCOHOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEXUAL DYSFUNCTION; TREATMENT OUTCOME;

EID: 0033861708     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000374-200007000-00015     Document Type: Article

References (53)

1. Anton RF, Moak DH, Lathan PK (1996) The Obsessive Compulsive Drinking Scale: A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 53:225-231.
2. Babor T, Dolinsky Z, Meyer R, Hesselbrock M, Hofmann M, Tennen H (1992) Types of alcoholics: Concurrent and predictive validity of some common classification schemes. Br J Addict 87:1415-1431.
3. Babor T, Dolinsky Z, Rounsaville B, Jaffe J (1988) Unitary versus multidimensional models of alcoholism treatment outcome: An empirical study. J Stud Alcohol 49:167-177.
4. Benkelfat C, Murphy D, Hill J, George DT, Nutt D, Linnoila M (1991) Ethanol like properties of the serotonergic partial agonist, m-chlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiatry 48:383.
5. Buydens-Branchey L, Branchey MH, Noumair D (1989a) Age of alcoholism onset. I. Relationship to psychopathology. Arch Gen Psychiatry 46:225-230.
6. Buydens-Branchey L, Branchey MH, Noumair D, Lieber CS (1989b) Age of alcoholism onset. II. Relationship to susceptibility to serotonin precursor availability. Arch Gen Psychiatry 46:231-236.
7. Coccaro E, Murphy D (1990) Serotonin in Major Psychiatric Disorders. American Psychiatric Press, Washington, DC.
8. Coccaro E, Siever L, Klar H, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL (1989) Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 46:587-599.
9. Cornelius J, Salloum I, Ehler J, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A (1997) Fluoxetine in depressed alcoholics. Arch Gen Psychiatry 54:700-705.
10. Coscina DV (1997) The biopsychology of impulsivity: Focus on brain serotonin, in Impulsivity (Webster CD, Jackson MA, eds). pp 95-115, Guilford Press, New York.
11. Del Boca FK, Kranzler HR, Brown J, Korner PF (1996) Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res 20:1412-1417.
12. Fils-Aime M, Eckhardt M, George D, Brown GL, Mefford I, Linnoila M (1996) Early-onset alcoholics have lower cerebral spinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics. Arch Gen Psychiatry 53:211-216.
13. Gorelick D, Pardes A (1992) Effect of fluoxetine on alcohol consumption in male alcoholics. Alcohol Clin Exp Res 16:261-265.
14. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
15. Heinz A, Ragan P, Jones D, Hommer D, Williams W, Knable MB, Gorey JG, Doty L, Geyer C, Lee KS, Coppola R, Weinberger DR, Linnoila M (1998) Reduced central serotonin transporters in alcoholism. Am J Psychiatry 155:1544-1549.
16. Higley J, Hasert M, Suomi S, Linnoila M (1998) The serotonin reuptake inhibitor sertraline reduces excessive alcohol consumption in nonhuman primates: Effect of stress. Neuropsychopharmacology 18:431-443.
17. Holmes T (1967) Life Change Index Scale, The Holmes and Rahe Social Readjustment Rating Scale. Pergamon Press, New York.
18. Irwin M, Schuckit M, Smith T (1990) Clinical importance of age at onset in type 1 and type 2 primary alcoholics. Arch Gen Psychiatry 47:320-324.
19. Johnson BA, Cloninger CR, Roache JD, Bordnick PF, Ruiz P (2000) Age of onset as a discrimination between alcoholic subtypes in a treatment-seeking outpatient population. Am J Addict 9:17-27.
20. Kabel D, Petty F (1996) A double-blind study of fluoxetine in severe alcohol dependence: Adjunctive therapy during and after inpatient treatment. Alcohol Clin Exp Res 20:780-784.
21. Kranzler H, Anton R (1994) Implications of recent neuropharmacologic research for understanding the etiology and development of alcoholism. J Cons Clin Psychology 62:1116-1126.
22. Kranzler HR, Burleson JA, Brown J, Babor TF (1996) Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in Type B alcoholics. Alcohol Clin Exp Res 20:1534-1541.
23. Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N (1995) Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152:391-397.
24. Krystal JH, Webb E, Cooney N, Kranzler HR, Charney DS (1994) Specificity of ethanol-like effects elicited by serotonergic and noradrenergic mechanisms. Arch Gen Psychiatry 51:898-911.
25. Krystal J, Webb E, Cooney N, Kranzler HR, Southwick SW, Heninger GR, Charney DS (1996) Serotonergic and noradrenergic dysregulation in alcoholism: m-CPP and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. Am J Psychiatry 153:83-92.
26. Lewis C (1991) Neurochemical mechanisms of chronic antisocial behavior (psychopathy): A literature review. J Nerv Men Dis 179:720-727.
27. Litt M, Babor T, DelBoca F, Kadden RM, Cooney NL (1992) Types of alcoholics. II. Application of an empirically derived typology to treatment matching. Arch Gen Psychiatry 49:609-614.
28. Maes M, Meltzer H (1995) The serotonin hypothesis of major depression, in Psychopharmacohgy: The Fourth Generation of Progress (Bloom F, Kupfer D, eds) pp 933-944, Raven Press, New York.
29. Mann J, Malone K, Diehl D, Perel J, Cooper TB, Mintun MA (1996) Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 153:174-182.
30. McLellan AT, Alterman AI, Cacciola J, Metzger D, O'Brien CP (1992a) A new measure of substance abuse treatment: Initial studies of the Treatment Services Review. J Nerv Ment Dis 180:100-110.
31. McLellan AT, Kushner AH, Metzger DS, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M (1992b) The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 9:199-213.
32. Meyers R, Quarfordt S (1991) Alcohol drinking attenuated by sertraline in rats with 6-OHDA or 5,7-DHT lesions of N. accumbens: A caloric response? Pharmacol Biochem Behav 40:923-928.
33. Moeller F, Dougherty D, Swann A, Collins D, Davis CM, Cherek DR (1996) Tryptophan depletion and aggressive responding in healthy males. Psychopharmacology (Berl)126:97-103.
34. Naranjo C, Kadlec K, Sanhueza P, Woodley-Remus D, Sellers EM (1990) Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 47:490-498.
35. Naranjo CA, Poulos CX, Bremner KE, Lanctot KL (1992) Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers. Clin Pharmacol Ther 51:729-739.
36. Naranjo C, Sellers E, Lawrin M (1986) Modulation of ethanol intake by serotonin uptake inhibitors. J Clin Psychiatry 47(suppl4):16-22.
37. Naranjo CA, Sellers EM, Roach CA, Woodley DV, Sanchez-Craig M, Sykora K (1984) Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers. Clin Pharmacol Ther 35:374-381.
38. Naranjo C, Sellers E, Sullivan J, Woodley DV, Kadlec K, Sykora K (1987) The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 41:266-274.
39. Naranjo C, Sullivan J, Kadlec K, Woodley-Remus DV, Kennedy G, Sellers EM (1989) Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clin Pharmacol Ther 46:3001-3009.
40. Norusis M (1997) SPSS 7.5 Guide to Data Analysis. Prentice Hall, Englewood Cliffs, NJ.
41. Nowinski J, Baker S, Carroll K (1995) Twelve-Step Facilitation Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals With Alcohol Abuse and Dependence. National Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland.
42. Pettinati HM (1996) Use of serotonin selective pharmacotherapy in the treatment of alcohol dependence. Alcohol Clin Exp Res 20 (Suppl): 23A-29A.
43. Pettinati HM, Volpicelli JR, Luck G, Kranzler HR, Rukstalis MR, Cnaan A (2000) Double-blind clinical trial of sertraline treatment for alcohol dependence. J Clin Psychopharm (in press).
44. Pettinati HM, Oslin DW, Decker K (2000) Role of serotonin and serotonin-selective pharmacotherapy in alcohol dependence. CNS Spectrums 5(2):33-46.
45. Sahakian B, Sarna G, Kantamaneni D, Jackson A, Hutson PH, Curzon G (1986) CSF tryptophan and transmitter amine turnover may predict social behaviour in the normal rat. Brain Res 399:162-166.
46. Schuckit M, Tipp J, Smith T, Shapiro E, Hesselbrock VM, Bucholz KK, Reich T, Nurnberger JI Jr (1995) An evaluation of Type A and B alcoholics. Addiction 90:1189-1203.
47. Selzer ML, Vinokur A, van Rooijen L (1975). A self-administered Short Michigan Alcoholism Screening Test (SMAST). J Stud Alcohol 36:117-126.
48. Sobell L, Sobell M (1992) Timeline follow-back: A technique for assessing self-reported alcohol consumption, in Measuring Alcohol Consumption (Litten R and Allen J eds). The Humana Press, Totowa, New Jersey.
49. Spitzer R, Williams J (1987) Structured Clinical Interview for DSM-III-R. 3rd ed., rev. American Psychiatric Association, Washington, DC.
50. Spitzer RL, Williams BW, Gibbon M, First MB (1992) The structured clinical interview for DSM-III-R (SCID). I. History, rationale, and description. Arch Gen Psychiatry 49:624-629.
51. Swann AC, Johnson BA, Cloninger CR, Chen YR (1999) Relationships of plasma tryptophan availability to course of illness and clinical features of alcoholism: A preliminary study. Psychopharm 143:380-384.
52. Virkkunen M, Linnoila M (1993) Brain serotonin, Type II alcoholism and impulsive violence. J Stud Alcohol 11(Suppl):163-169.
53. Virkkunen M, Narvanen S (1987) Plasma insulin, tryptophan and serotonin levels during the glucose tolerance test among habitually violent and impulsive offenders. Neuropsychobiology 17(1-2):19-23.